Duchenne muscular dystrophy is a severe pediatric neuromuscular disorder caused by the
lack of dystrophin. Identification of biomarkers is needed to support and accelerate drug …

Background Duchenne muscular dystrophy (DMD) is a fatal genetic muscle-wasting disease
that affects 1 in 5000 male births with no current cure. Despite great progress has been …

Serum metabolite profiling in Duchenne muscular dystrophy (DMD) may enable discovery of
valuable molecular markers for disease progression and treatment response. Serum …

Duchenne muscular dystrophy is a deadly muscle-wasting disorder caused by loss of
dystrophin protein. Studies suggest that metabolic alterations are important to disease …

Duchenne muscular dystrophy is the most common form of muscular dystrophy. Genetic and
biochemical research over the years has characterized the cause, pathophysiology and …

Functional genomic studies are dominated by transcriptomic approaches, in part reflecting
the vast amount of information that can be obtained, the ability to amplify mRNA and the …

Duchenne muscular dystrophy (DMD) is caused by genetic mutations leading to lack of
dystrophin in skeletal muscle. A better understanding of how objective biomarkers for DMD …

Duchenne muscular dystrophy (DMD) is a musculoskeletal disorder that causes severe
morbidity and reduced lifespan. Individuals with DMD have an X-linked mutation that impairs …

ABSTRACT Purpose/Aim Duchenne muscular dystrophy (DMD) is a progressive
neuromuscular disease characterized by extensive muscle weakness. Patients with DMD …

Background Duchenne muscular dystrophy (DMD) is a severe form of muscular dystrophy
without an effective treatment, caused by mutations in the DMD gene, leading to the …